Cure enters this GSL Season 2 Group Stage BO3 with superior recent form as a consistent top-tier Terran, advancing through qualifiers and posting strong results in the round of 12 while demonstrating reliable TvP execution. sOs, a veteran Protoss known for creative and unpredictable builds, has shown inconsistency lately, including a prior 0-2 loss to Cure in the same season and mixed showings against other Code S players. Head-to-head trends favor Cure in recent series, and the current map pool plus meta leanings toward aggressive Terran timing attacks further tilt implied probabilities toward the higher-ranked player. Roster stability and no reported issues for either competitor keep focus on execution and adaptation in the best-of-three format.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCure – sOs




Moneyline
$110 Vol.
Map 1 Winner
$860 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Mercato aperto: May 19, 2026, 6:00 PM ET
Fonte di risoluzione
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure – sOs




Moneyline
$110 Vol.
Map 1 Winner
$860 Vol.
Map Handicap
$100 Vol.
Total Games
$100 Vol.
This market will resolve to "Cure" if Cure win the match against sOs.
This market will resolve to "sOs" if sOs win the match against Cure.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Mercato aperto: May 19, 2026, 6:00 PM ET
Fonte di risoluzione
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...Cure enters this GSL Season 2 Group Stage BO3 with superior recent form as a consistent top-tier Terran, advancing through qualifiers and posting strong results in the round of 12 while demonstrating reliable TvP execution. sOs, a veteran Protoss known for creative and unpredictable builds, has shown inconsistency lately, including a prior 0-2 loss to Cure in the same season and mixed showings against other Code S players. Head-to-head trends favor Cure in recent series, and the current map pool plus meta leanings toward aggressive Terran timing attacks further tilt implied probabilities toward the higher-ranked player. Roster stability and no reported issues for either competitor keep focus on execution and adaptation in the best-of-three format.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoFai attenzione ai link esterni.
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti